Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal, Humanized
  • Brain
  • Brain Neoplasms
  • Radiation Injuries
  • Radiosurgery

abstract

  • Bevacizumab is effective and safe for the treatment of RN after SRS for brain metastasis. In this context, bevacizumab offers symptomatic relief, a reduction in steroid requirement, and a dramatic radiographic response.

publication date

  • September 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3748921

Digital Object Identifier (DOI)

  • 10.1093/neuonc/not085

PubMed ID

  • 23814264

Additional Document Info

start page

  • 1257

end page

  • 63

volume

  • 15

number

  • 9